Cargando…

Signal Increase on Unenhanced T1-Weighted Images in the Rat Brain After Repeated, Extended Doses of Gadolinium-Based Contrast Agents: Comparison of Linear and Macrocyclic Agents

OBJECTIVES: In this prospective preclinical study, we evaluated T1-weighted signal intensity in the deep cerebellar nuclei (CN) and globus pallidus (GP) up to 24 days after repeated administration of linear and macrocyclic gadolinium-based contrast agents (GBCAs) using homologous imaging and evaluat...

Descripción completa

Detalles Bibliográficos
Autores principales:	Jost, Gregor, Lenhard, Diana Constanze, Sieber, Martin Andrew, Lohrke, Jessica, Frenzel, Thomas, Pietsch, Hubertus
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Lippincott Williams & Wilkins 2016
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4747981/ https://www.ncbi.nlm.nih.gov/pubmed/26606548 http://dx.doi.org/10.1097/RLI.0000000000000242

Ejemplares similares

Histology and Gadolinium Distribution in the Rodent Brain After the Administration of Cumulative High Doses of Linear and Macrocyclic Gadolinium-Based Contrast Agents
por: Lohrke, Jessica, et al.
Publicado: (2017)

Gadolinium Accumulation in the Deep Cerebellar Nuclei and Globus Pallidus After Exposure to Linear but Not Macrocyclic Gadolinium-Based Contrast Agents in a Retrospective Pig Study With High Similarity to Clinical Conditions
por: Boyken, Janina, et al.
Publicado: (2018)

Penetration and distribution of gadolinium-based contrast agents into the cerebrospinal fluid in healthy rats: a potential pathway of entry into the brain tissue
por: Jost, Gregor, et al.
Publicado: (2016)

Quantification and Assessment of the Chemical Form of Residual Gadolinium in the Brain After Repeated Administration of Gadolinium-Based Contrast Agents: Comparative Study in Rats
por: Frenzel, Thomas, et al.
Publicado: (2017)

Preclinical Profile of Gadoquatrane: A Novel Tetrameric, Macrocyclic High Relaxivity Gadolinium-Based Contrast Agent
por: Lohrke, Jessica, et al.
Publicado: (2022)

Impact of brain tumors and radiotherapy on the presence of gadolinium in the brain after repeated administration of gadolinium-based contrast agents: an experimental study in rats
por: Jost, Gregor, et al.
Publicado: (2019)

The Effect of Gadolinium-Based Contrast Agents on Longitudinal Changes of Magnetic Resonance Imaging Signal Intensities and Relaxation Times in the Aging Rat Brain
por: Green, Claudia, et al.
Publicado: (2022)

Impact of Treatment With Chelating Agents Depends on the Stability of Administered GBCAs: A Comparative Study in Rats
por: Boyken, Janina, et al.
Publicado: (2019)

Differences in gadolinium retention after repeated injections of macrocyclic MR contrast agents to rats
por: Bussi, Simona, et al.
Publicado: (2017)

T1-Weighted Hypersignal in the Deep Cerebellar Nuclei After Repeated Administrations of Gadolinium-Based Contrast Agents in Healthy Rats: Difference Between Linear and Macrocyclic Agents
por: Robert, Philippe, et al.
Publicado: (2015)

Synthesis of a gadolinium based-macrocyclic MRI contrast agent for effective cancer diagnosis
por: Jeong, Yohan, et al.
Publicado: (2018)

Gadolinium retention and clearance after administration of macrocyclic magnetic resonance contrast agents to rats
por: Bussi, Simona, et al.
Publicado: (2019)

Macrocyclic MR contrast agents: evaluation of multiple-organ gadolinium retention in healthy rats
por: Bussi, Simona, et al.
Publicado: (2020)

Linear Gadolinium-Based Contrast Agents Are Associated With Brain Gadolinium Retention in Healthy Rats
por: Robert, Philippe, et al.
Publicado: (2016)

The Impact of Injector-Based Contrast Agent Administration on Bolus Shape and Magnetic Resonance Angiography Image Quality
por: Jost, Gregor, et al.
Publicado: (2017)

The New Restrictions on the Use of Linear Gadolinium-based Contrast Agents in Japan
por: Kanda, Tomonori
Publicado: (2018)

Gadolinium deposition in the brain of dogs after multiple intravenous administrations of linear gadolinium based contrast agents
por: Richter, Henning, et al.
Publicado: (2020)

Visible T1-hyperintensity of the dentate nucleus after multiple administrations of macrocyclic gadolinium-based contrast agents: yes or no?
por: Splendiani, Alessandra, et al.
Publicado: (2019)

Gadolinium contrast agents: Over exposure?
por: Biederman, Robert W, et al.
Publicado: (2016)

Gadolinium Retention in the Brain of Mother and Pup Mouse: Effect of Pregnancy and Repeated Administration of Gadolinium‐Based Contrast Agents
por: Yao, Xiang, et al.
Publicado: (2022)

Analytical Interference in Serum Iron Determination Reveals Iron Versus Gadolinium Transmetallation With Linear Gadolinium-Based Contrast Agents
por: Fretellier, Nathalie, et al.
Publicado: (2014)

Gadolinium-DTPA: A New Contrast Agent
por: Niendorf, H. P.
Publicado: (1988)

Up to 52 administrations of macrocyclic ionic MR contrast agent are not associated with intracranial gadolinium deposition: Multifactorial analysis in 385 patients
por: Lee, Ji Ye, et al.
Publicado: (2017)

Gadolinium Complexes as Contrast Agent for Cellular NMR Spectroscopy
por: Sakol, Nat, et al.
Publicado: (2020)

Comparison of linear versus macrocyclic gadolinium chelates in rat skeletal muscle
por: Balik, Mehmet Sabri, et al.
Publicado: (2022)

Biocompatible Polyhydroxyethylaspartamide-based Micelles with Gadolinium for MRI Contrast Agents
por: Jeong, Sang Young, et al.
Publicado: (2010)

Immediate reaction to gadolinium based contrast agent with fatal outcome()()()
por: Behzadi, Ashkan Heshmatzadeh, et al.
Publicado: (2018)

Gadolinium-Based Contrast Agents Hypersensitivity: A Case Series
por: Nucera, Eleonora, et al.
Publicado: (2021)

Gadolinium-based contrast agents in neurofibromatosis type 1 (Review)
por: Năstase, Florentina, et al.
Publicado: (2021)

Recent Advances in Gadolinium Based Contrast Agents for Bioimaging Applications
por: Fatima, Atiya, et al.
Publicado: (2021)

Methodological Aspects for Preclinical Evaluation of Gadolinium Presence in Brain Tissue: Critical Appraisal and Suggestions for Harmonization—A Joint Initiative
por: Robert, Philippe, et al.
Publicado: (2018)

The presence of the gadolinium-based contrast agent depositions in the brain and symptoms of gadolinium neurotoxicity - A systematic review
por: Olchowy, Cyprian, et al.
Publicado: (2017)

Geometrical confinement of gadolinium-based contrast agents in nanoporous particles enhances T(1) contrast
por: Ananta, Jeyarama S., et al.
Publicado: (2010)

Thermal Excitation of Gadolinium-Based Contrast Agents Using Spin Resonance
por: Dinger, Steven C., et al.
Publicado: (2016)

Acute respiratory distress syndrome after the use of gadolinium contrast agent
por: Kerget, Bugra, et al.
Publicado: (2018)

Effect of different doses of gadolinium contrast agent on clinical outcomes in MS
por: Ackermans, Nathalie, et al.
Publicado: (2019)

Investigating the Impact of Gadolinium-Based Contrast Agents on the Corrected QT Interval
por: Gress, Kyle L, et al.
Publicado: (2020)

PEG-modified gadolinium nanoparticles as contrast agents for in vivo micro-CT
por: Cruje, Charmainne, et al.
Publicado: (2021)

Formation of gadolinium–ferritin from clinical magnetic resonance contrast agents
por: Neburkova, Jitka, et al.
Publicado: (2020)

Gadolinium as a contrast agent for infusion sialograms in patients with iodine allergy
por: Sabotin, Ryan P., et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_c05j2flug32dpcgodvsvt41p7e